Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

01/02/2018 04:30

Feb 1 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             76.89               78.97           101.70     
                 (-2.6 pct)          (-7.6 pct)       (+0.2 pct)   
  Operating         23.71               24.95            26.80     
                 (-5.0 pct)          (-16.0 pct)      (-12.7 pct)  
  Recurring         24.06               25.23            27.00     
                 (-4.6 pct)          (-15.7 pct)      (-12.9 pct)  
  Net               16.86               17.98            19.10     
                 (-6.3 pct)          (-10.7 pct)      (-13.2 pct)  
  EPS            416.06 yen          437.85 yen       473.71 yen   
  Ann Div                            150.00 yen       150.00 yen   
  -Q2 div         75.00 yen           75.00 yen                    
  -Q4 div                             75.00 yen        75.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T 
  ((Tokyo Headline News Desk +813 6441 1812))